DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Labetalol (Labetalol Hydrochloride) - Summary

 

-- advertisement --

LABETALOL SUMMARY

LABETALOL HYDROCHLORIDE
TABLETS, USP

Labetalol HCl is an adrenergic receptor blocking agent that has both selective alpha1- and nonselective beta-adrenergic receptor blocking actions in a single substance.

Labetalol HCl Injection is indicated for control of blood pressure in severe hypertension.

LABETALOL NEWS HIGHLIGHTS

Published Studies Related to Labetalol

Benzodiazepine and opioid sedation attenuate the sympathetic response to fiberoptic bronchoscopy. Prophylactic labetalol gave no additional benefit. Results of a randomized double-blind placebo-controlled study. [2008.07]

Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial. [2006.09]

Pharmacokinetic interaction studies of atosiban with labetalol or betamethasone in healthy female volunteers. [2005.11]

more>>

Clinical Trials Related to Labetalol

Effects of Labetalol on Human Cocaine Use - 8 [Completed]

Effects of Labetalol on Nicotine Administration in Humans - 14 [Completed]

Labetalol Versus MgSO4 for the Prevention of Eclampsia Trial [Recruiting]

Labetalol to Prevent Hypertension and Tachycardia During Fiberoptic Bronchoscopy [Completed]

Treatment Targets for Chronic Hypertension in Pregnancy [Recruiting]

more>>

Page last updated: 2008-06-22

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008